Aytu BioPharma, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 3 3 4 7 28 66 97 107 81
Przychód Δ r/r 0.0% 0.0% inf% -100.0% 0.0% inf% 0.0% 3267.4% 344.2% 878.8% 25.7% 13.6% 100.0% 277.5% 137.5% 47.3% 11.1% -24.6%
Marża brutto 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% 2857.1% 100.0% 66.3% 62.6% 56.0% 44.0% 69.9% 72.7% 44.5% 54.1% 62.0% 67.4%
EBIT (mln) -0 -0 -0 -0 -0 -0 -0 -6 -8 -22 -20 -20 -17 -21 -38 37 -17 -5
EBIT Δ r/r 0.0% 17.3% 1.5% 1.6% 135.5% -57.8% -7.0% 12009.0% 20.3% 184.4% -7.3% -2.1% -14.5% 24.3% 82.7% -197.3% -145.9% -69.2%
EBIT (%) 0.0% 0.0% -3189.8% 0.0% 0.0% -3220.3% -2995.1% -10770.3% -2915.5% -847.0% -624.7% -538.3% -230.1% -75.8% -58.3% 38.5% -15.9% -6.5%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 5 3 1 0 0 0 147 0 5
EBITDA (mln) -0 -0 -0 -0 -0 -0 -0 -6 -8 -13 -14 -9 -4 -25 -14 41 -8 -1
EBITDA(%) 0.0% 0.0% -2716.5% 0.0% 0.0% -2868.9% -2712.7% -10604.9% -2870.4% -520.2% -449.9% -245.2% -59.7% -89.1% -22.1% 42.7% -7.1% -1.2%
Podatek (mln) 0 0 0 -0 0 0 1 -1 -0 8 1 -2 20 -10 0 -0 -0 2
Zysk Netto (mln) -0 -0 -0 -0 -0 -0 -0 -6 -8 -28 -23 -10 -47 -4 -58 -110 -17 -16
Zysk netto Δ r/r 0.0% 16.8% 3.0% 2.3% 127.0% -56.4% -3.9% 9632.9% 38.4% 264.9% -20.1% -54.7% 363.0% -92.2% 1475.5% 89.0% -84.5% -7.1%
Zysk netto (%) 0.0% 0.0% -3365.4% 0.0% 0.0% -3410.0% -3275.3% -9466.8% -2950.3% -1099.7% -698.7% -278.4% -644.3% -13.4% -88.8% -114.0% -15.9% -19.6%
EPS -48954.0 -11434.6 -11778.8 -10045.0 -17100.25 -7459.37 -7164.75 0.0 0.0 0.0 0.0 0.0 -1210.28 -16.37 -69.61 -1499.1 -5.11 -2.86
EPS (rozwodnione) -48954.0 -11434.6 -11778.8 -10045.0 -17100.25 -7459.37 -7164.75 0.0 0.0 0.0 0.0 0.0 -1210.28 -16.37 -69.61 -1499.1 -5.11 -2.86
Ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 6
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 6
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD